Literature DB >> 8844207

Spectrin mutations in hereditary elliptocytosis and hereditary spherocytosis.

P Maillet1, N Alloisio, L Morlé, J Delaunay.   

Abstract

Hereditary elliptocytosis (HE), its aggravated form hereditary pyropoikilocytosis (HPP), and hereditary spherocytosis (HS) designate a set of congenital hemolytic syndromes. The responsible mutations lie in several genes encoding proteins of the red cell membrane. In particular, they involve the SPTA1 and SPTB genes that encode erythroid spectrin alpha- and beta-chains, respectively. In situ, spectrin is a alpha 2 beta 2 fibrillar tetramer resulting from the head-to-head self-association of two alpha beta dimers. In HE, the 24 known alpha-chain mutations lie in the self-association site or its vicinity, whereas the 17 beta-chain mutations occur in the self-association site itself (record of November 30, 1995). Allele alpha LELY (LELY: Low Expression LYon) is found in ethnic groups remote from one another with a uniform frequency (20-30% of all alpha-alleles). It allows an expanded expression of any HE alpha-allele located in trans and results in severe HE or in HPP. In HS, a number of spectrin mutations have been recorded recently. Allele alpha LEPRA (LEPRA: Low Expression PRAgue) would occur in a recurrent fashion.

Entities:  

Mesh:

Year:  1996        PMID: 8844207     DOI: 10.1002/(SICI)1098-1004(1996)8:2<97::AID-HUMU1>3.0.CO;2-M

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  9 in total

1.  Red cell membrane disorders: structure meets function.

Authors:  Mary Risinger; Theodosia A Kalfa
Journal:  Blood       Date:  2020-09-10       Impact factor: 22.113

2.  Genotype-phenotype correlations in hereditary elliptocytosis and hereditary pyropoikilocytosis.

Authors:  Omar Niss; Satheesh Chonat; Neha Dagaonkar; Marya O Almansoori; Karol Kerr; Zora R Rogers; Patrick T McGann; Maa-Ohui Quarmyne; Mary Risinger; Kejian Zhang; Theodosia A Kalfa
Journal:  Blood Cells Mol Dis       Date:  2016-07-17       Impact factor: 3.039

3.  Diagnostic tool for red blood cell membrane disorders: Assessment of a new generation ektacytometer.

Authors:  Lydie Da Costa; Ludovic Suner; Julie Galimand; Amandine Bonnel; Tiffany Pascreau; Nathalie Couque; Odile Fenneteau; Narla Mohandas
Journal:  Blood Cells Mol Dis       Date:  2015-09-16       Impact factor: 3.039

4.  Spectrin Tunis (Sp alpha (I/78)) in a Korean family with hereditary elliptocytosis.

Authors:  Eunhee Han; Ahhyun Kim; Joonhong Park; Myungshin Kim; Yonggoo Kim; Kyungja Han; Yoo-Jin Kim
Journal:  Ann Lab Med       Date:  2013-08-08       Impact factor: 3.464

5.  Identification of proteomic markers for prediction of the response to 5-Fluorouracil based neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.

Authors:  Jianan Wang; Jiayu Liu; Jinyang Wang; Shijian Wang; Feifei Li; Ruibing Li; Peng Liu; Mianyang Li; Chengbin Wang
Journal:  Cancer Cell Int       Date:  2022-03-15       Impact factor: 5.722

6.  Mechanism of assembly of the non-covalent spectrin tetramerization domain from intrinsically disordered partners.

Authors:  Stephanie A Hill; Lee Gyan Kwa; Sarah L Shammas; Jennifer C Lee; Jane Clarke
Journal:  J Mol Biol       Date:  2013-09-17       Impact factor: 6.151

7.  Hereditary elliptocytosis-associated alpha-spectrin mutation p.L155dup as a modifier of sickle cell disease severity.

Authors:  Mary Risinger; Georgios E Christakopoulos; Corinna L Schultz; Patrick T McGann; Wenying Zhang; Theodosia A Kalfa
Journal:  Pediatr Blood Cancer       Date:  2018-11-04       Impact factor: 3.167

8.  The genomic landscape of Mongolian hepatocellular carcinoma.

Authors:  Julián Candia; Enkhjargal Bayarsaikhan; Mayank Tandon; Anuradha Budhu; Marshonna Forgues; Lkhagva-Ochir Tovuu; Undarmaa Tudev; Justin Lack; Ann Chao; Jigjidsuren Chinburen; Xin Wei Wang
Journal:  Nat Commun       Date:  2020-09-01       Impact factor: 14.919

9.  A novel genomic classification system of gastric cancer via integrating multidimensional genomic characteristics.

Authors:  Haiyong Wang; Yongfeng Ding; Yanyan Chen; Junjie Jiang; Yiran Chen; Jun Lu; Mei Kong; Fan Mo; Yingying Huang; Wenyi Zhao; Ping Fang; Xiangliu Chen; Xiaodong Teng; Nong Xu; Yimin Lu; Xiongfei Yu; Zhongqi Li; Jing Zhang; Haohao Wang; Xuanwen Bao; Donghui Zhou; Ying Chi; Tianhua Zhou; Zhan Zhou; Shuqing Chen; Lisong Teng
Journal:  Gastric Cancer       Date:  2021-06-06       Impact factor: 7.701

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.